Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Balazs

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Plos One|November 15, 2019
Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsidsQin Huang, Ken Y Chan, Isabelle G Tobey, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Heterologous sarbecovirus receptor binding domains as scaffolds for SARS-CoV-2 receptor binding motif presentationBlake M Hauser, Maya Sangesland, Evan C Lam, et al.
Open Forum Infectious Diseases|March 2, 2023
Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare WorkersMichael L Freeman, Oladayo A Oyebanji, Daniela Moisi, et al.
Biorxiv : the Preprint Server for Biology|December 17, 2020
Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motifBlake M Hauser, Maya Sangesland, Evan C Lam, et al.
Cancer Cell|January 6, 2022
Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancerVivek Naranbhai, Kerri J St Denis, Evan C Lam, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2021
Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapyCynthia L Bowes, Vivek Naranbhai, Kerri J St Denis, et al.
NPJ Vaccines|December 3, 2022
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in childrenYannic C Bartsch, Jessica W Chen, Jaewon Kang, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challengeUrjeet S Khanwalkar, Jennifer Fields, Joshua A Wiener, et al.
The Journal of Experimental Medicine|September 26, 2022
Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidityIara M Backes, Brook K Byrd, Matthew D Slein, et al.
Blood Advances|September 20, 2023
De novo hematopoiesis from the fetal lungAnthony K Yeung, Carlos Villacorta-Martin, Jonathan Lindstrom-Vautrin, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Plos One|November 15, 2019
Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsidsQin Huang, Ken Y Chan, Isabelle G Tobey, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Heterologous sarbecovirus receptor binding domains as scaffolds for SARS-CoV-2 receptor binding motif presentationBlake M Hauser, Maya Sangesland, Evan C Lam, et al.
Open Forum Infectious Diseases|March 2, 2023
Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare WorkersMichael L Freeman, Oladayo A Oyebanji, Daniela Moisi, et al.
Biorxiv : the Preprint Server for Biology|December 17, 2020
Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motifBlake M Hauser, Maya Sangesland, Evan C Lam, et al.
Cancer Cell|January 6, 2022
Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancerVivek Naranbhai, Kerri J St Denis, Evan C Lam, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2021
Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapyCynthia L Bowes, Vivek Naranbhai, Kerri J St Denis, et al.
NPJ Vaccines|December 3, 2022
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in childrenYannic C Bartsch, Jessica W Chen, Jaewon Kang, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challengeUrjeet S Khanwalkar, Jennifer Fields, Joshua A Wiener, et al.
The Journal of Experimental Medicine|September 26, 2022
Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidityIara M Backes, Brook K Byrd, Matthew D Slein, et al.
Blood Advances|September 20, 2023
De novo hematopoiesis from the fetal lungAnthony K Yeung, Carlos Villacorta-Martin, Jonathan Lindstrom-Vautrin, et al.
Pageof 11